Pfizer Inc at Evercore ISI HealthCONx Virtual Conference Transcript
Hello, everyone. Thank you for joining us. Pleasure to have Pfizer management join us. There's a lot to talk about, but at the outset, I do want to say that when we were first scheduling this event, there was a lot of interest at Pfizer at the time. And this was -- we were doing this in the -- in -- during the summer, and there was a lot of interest at Pfizer at the time to talk about some of the innovation areas that aren't getting necessarily much Street focus, which included obviously an emerging gene therapy pipeline. And one of the goals at this fireside when we were first setting it up was to have Bob Smith, who's -- who could really take us through the gene therapy business in a lot of detail. But of course, we couldn't have predicted that 3 days before this fireside chat, there would obviously be a new and crazy variant.
So in light of that, we're going to start off with a few variant questions, if that's okay. But let me first turn it over to Chris, who's the new head
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |